Cinclus Pharma participates at Redeye Growth Day May 2024
Cinclus Pharma participates at Redeye Growth Day May 30th. Christer Ahlberg, CEO of Cinclus Pharma, will present the company and the development of linaprazan glurate.
Read more
News
Check out the latest news from Cinclus Pharma
Presentation of the company and the development of linaprazan glurate from Avanza's Börsdag
Here you can watch the full presentation (in Swedish) of Cinclus Pharma and the development of linaprazan glurate, held by CEO Christer Ahlberg at Avanza’s Börsdag.
Read more
Cinclus Pharma participates at Avanza's Börsdag
Cinclus Pharma's CEO Christer Ahlberg, will talk about the company's latest updates and the development of linaprazan glurate at Avanza's Börsdag on May 22nd.
Read more